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To understand the normal aging pro-cess, as well as the role of cellular
aging in diseases such as cancer, it is
essential to understand the process of
somatic cell development and renewal.
Stem cells are undifferentiated cells, nor-
mally residing in a specific location (a
niche) within a tissue. Stem cells are ca-
pable of producing a variety of somatic
cell types needed for periodic tissue re-
newal and tissue regeneration after injury.
To accomplish this, stem cells produce
intermediate progenitors, called transit
amplifying (TA) cells, that can divide rap-
idly and differentiate into various types of
tissue cells. Because stem cells are the only
cells capable of continuous tissue renewal,
the population of stem cells must be main-
tained. It is still largely a mystery how stem
cells maintain their numbers. Two com-
peting models have been proposed (1, 2)
(Fig. 1). The deterministic model pro-
poses that a small number of stem cells
reside in a niche, each generating exactly
one stem cell and one TA cell at each
(asymmetrical) cell division. The daughter
TA cell leaves the niche to proliferate for
tissue renewal while the daughter stem cell
remains in the niche; each stem cell is
‘‘immortal’’ under this model. The sto-
chastic model proposes that many stem
cells exist in a niche with each stem cell
division producing either two, one, or zero
stem cells (and either zero, one, or two
proliferating TA cells, respectively). This
leads to ‘‘drift’’ in the numbers of descen-
dents of each stem cell lineage over time.
Eventually, a single common ancestral
stem cell exists from which all stem cells in
a niche are descended. The stem cell
population is most likely to persist (under
the stochastic model) if the probability
that a stem cell division produces either
two stem cells, or zero stem cells, is equal.
In this issue of PNAS, Yatabe et al. (3)
demonstrate how random changes in
methylation patterns at CpG sites within
particular genes can be used to study the
dynamics of stem cells in human colon
crypts. Methylation refers to the covalent
addition of a methyl group to a DNA
residue; in the mammalian genome, the
addition of a methyl group to the fifth
position of the cytosine ring within a CpG
dinucleotide is most common (4, 5).
Yatabe et al. (3) use their method to test
deterministic and stochastic models of
stem cell division and conclude that a
stochastic model is more consistent with
their data.
Given the importance of cellular popu-
lation dynamics to a complete understand-
ing of stem cell biology, it is no surprise
that cell fate mapping has become one of
the hottest areas of stem cell research. Cell
fate mapping methods used in mice typi-
cally involve following the fate of cells
labeled with either radioactive, or histo-
chemical tags, or following the fate of cells
in chimeric mice (6–8). Alternatively, ini-
tial variability can be induced at genetic
markers through mutagenesis; a subse-
quent loss of variation at these genetic
markers (over time and space) provides
information about the dynamics of cell
turnover (9). Neither of these approaches
can be used to study stem cell turnover in
humans and it is difficult to generalize
results from mice to humans because of
differences in lifespan (number of cell
divisions) and the larger numbers of cells
that make up organs and tissues in hu-
mans. The methylation-based strategy of
Yatabe et al. (3) provides a practical ap-
proach for studying stem cell dynamics in
humans. The basic idea is that epigenetic
variants with different patterns of meth-
ylation at CpG sites arise during stem cell
division and the distribution of the vari-
ants among, and within, tissue regions
conveys information about stem cell pop-
ulation dynamics.
It is well known that changes in levels of
DNA methylation modify gene expression
and chromatin structure (10, 11). These
changes are regulated by specific enzymes
and are of functional significance. How-
ever, if one considers changes in the meth-
ylation patterns of CpG sites in genes that
are not expressed in cells of a particular
tissue, these changes are likely to have no
functional significance for cells of that
tissue. The changes in methylation pat-
terns, in this case, are not caused by gene
regulation but instead arise by a random
process of methylation associated with
cellular aging, much like DNA mutations,
but occurring at a higher rate. The pat-
terns of methylation at particular sites in a
nonexpressed gene are therefore ‘‘neu-
tral’’ genetic markers that can be used to
study cell fates. The basic idea is that the
methylation of CpG sites in these genes
occurs over time according to a stochastic
process with a rate (roughly 1025) that is
much higher than the rate of DNA muta-
tion (roughly 1029).
Yatabe et al. (3) assume that all of the
CpG sites they examine are initially un-
methylated (at birth) and that sites be-
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Fig. 1. Deterministic and stochastic models of
stem cell population dynamics. Open circles repre-
sent stem cells and filled circles represent TA cells.
The probability that either two stem cells (and no
TA cells), or two TA cells (and no stem cells) result
from the division of a stem cell is q. The probability
that one stem cell and one TA cell result is P. The
deterministic model assumes that q 5 0 and P 5 1
and the stochastic model assumes that P , 1 and
q . 0.
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come methylated (at random) as cells
divide over time. Evidence suggests that
there is somatic inheritance of methylated
sites (12). The combinations of methyl-
ated CpG sites, within each gene (referred
to as tags), that accumulate within cellular
lineages over time carry information
about the genealogical relationships
among these lineages (at the cellular level)
and allow different models of stem cell
turnover to be tested (by comparing pre-
dicted patterns of methylation under
mathematical models of cell division, and
random methylation, with observed pat-
terns). If a target gene has N CpG sites
(methylation tags) that are assayed, then
each site is a binary marker (unmethylat-
ed 5 0, methylated 5 1). Because each site
must assume one of these two states, there
are 2N possible distinct methylation pat-
terns of the gene in any cell, yielding a
large number of unique tags. For example,
if N 5 8 CpG sites occur within a gene,
there are 256 unique tags. Three examples
of unique tags are 00000001, 00110010,
and 11101110.
Techniques for determining whether a
cytosine nucleotide (C) is methylated, or
unmethylated, are well established (13).
Treatment of DNA with bisulfite converts
unmethylated C into uracil (U), but meth-
ylated C is unaltered (14). PCR amplifi-
cation and sequencing then reveals the
site-specific pattern of methylation (i.e., C
versus T) in a bisulfite-treated sequence.
Yatabe et al. (3) studied the methylation
status of five, eight, and nine CpG sites,
respectively, in the MYOD1, CSX, and
BGN genes (none of which are expressed
in colon crypt cells). Between seven and
nine normal colon crypts were obtained
from each of 14 patients having under-
gone colectomies. Samples of at least five
clones (molecules) from each crypt were
analyzed to examine methylation patterns
in the three genes. This allowed diversity
of methylation patterns to be examined
both within, and between, colon crypts.
Colon crypts are straight tubular glands,
which mainly consist of goblet (mucous)
cells that continuously secrete mucin to
lubricate the bowel, facilitating the pas-
sage of the colonic contents. A single crypt
is thought to be a proliferative unit, which
is renewed about every 6 days by a stem
cell niche located at the bottom of a crypt.
The lower third of the crypt constitutes
the proliferative zone where newly gener-
ated TA cells undergo 2–3 additional di-
visions as they begin their migration up
the crypt (15, 16).
Yatabe et al. (3) used several statistics
to summarize the methylation patterns
within and among crypts. One measure
used in their analyses is the epigenetic
distance between a pair of molecules. This
is calculated (for a particular gene) as the
total number of CpG sites at which the two
molecules differ. For example, if an anal-
ysis of MYOD1 for two molecules sampled
from within a single crypt yielded 01001
and 00101, then the epigenetic distance is
2. Epigenetic distances among pairs of
molecules sampled from a single crypt are
called intracrypt distances; those among
pairs of molecules sampled from different
crypts are called intercrypt distances. The
authors found that intercrypt distances
were greater, on average, than intracrypt
distances, but both distances were highly
variable. Another important statistic is the
number of unique tags per crypt; this is the
total number of unique tags found in the
complete sample of molecules from a
crypt that are bisulfite-treated, PCR-
amplified, and sequenced. In general, an
increase in the relative magnitude of in-
tracrypt versus intercrypt distances sug-
gests a greater number of stem cells per
niche.
To evaluate alternative models of stem
cell turnover, Yatabe et al. (3) calculated
the variance of the observed number of
unique tags per crypt for samples from
each of the 14 patients. The expected
variance under each model of stem cell
turnover was obtained by computer sim-
ulation. The stem cell models considered
by these authors are instances of a condi-
tional branching process model studied by
Cannings (17) and can be readily simu-
lated. The deterministic and stochastic
stem cell turnover models can be viewed
as special cases of a general model (Fig. 1).
Define P to be the probability that one
stem cell and one TA cell are produced at
a cell division, and let q be the probability
that either zero stem cells, or two stem
cells, are produced. Note that P 1 2 q 5
1 and therefore q 5 (1 2 P)y2 so that P is
the only free parameter. The determinis-
tic stem cell model specifies that P 5 1,
and under the alternative (stochastic)
model P , 1. A second
parameter of both
models is the number
of stem cells, n, per
niche. Yatabe et al.
(3) compared the ob-
served variances of the
number of unique tags
per crypt (for each pa-
tient) with the expected
variance under two
combinations of model
parameters: a deter-
ministic stem cell model with P 5 1 and
n 5 2; a stochastic stem cell model with P
ranging from 0.75 to 0.95 and n ranging
from 4 to 512. The observed distribution
of variance was most consistent with a
stochastic model, but a broad range of
values of P and n were possible.
An interesting aspect of the intracrypt
stem cell genealogy considered by Yatabe
et al. (3) is the expected age of the most
recent common ancestral (MRCA) stem
cell of a niche (under the stochastic mod-
el). Assuming a 64-stem cell niche, they
calculated that the MRCA of a crypt
existed about 3,000 cell divisions in the
past (on average). Assuming one stem cell
division per day, this would suggest a stem
cell bottleneck, for any given crypt, about
every 8.2 years, on average. Similarly, the
expected time to fixation, or loss, of a
newly arisen mutant stem cell was pre-
dicted to be about 220 days. The authors
point out that this figure roughly agrees
with the clonal stabilization time of 1 year
observed for human crypt heterogeneity
after irradiation (18). Parameters such as
the age of the MRCA of a population
sample, or the time to fixation, or loss, of
an allele in a population have long been a
focus of interest for population geneti-
cists, and the utility of these measures for
studying population demography, and
other aspects of population structure, is
now widely accepted (19). The study of
Yatabe et al. (3) demonstrates that anal-
ogous parameters may have a high degree
of biological relevance for the study of
population dynamics at the cellular level.
In the field of population genetics,
much work has recently been devoted to
the development of methods for estimat-
ing the ages of alleles (20). It has become
clear that there are two potential sources
of information about allele age: allele
frequency (more frequent alleles tend to
be older), and variation at genetic markers
closely linked to the mutation defining the
allele (more variation at linked markers
usually suggests an older age). In some
cases, natural selection favoring a muta-
tion can greatly increase its population
frequency (suggesting an old age if the
allele were assumed to be neutral) despite
its young age, but the lack of variation at
linked genetic markers will still suggest a
young age for the allele
despite its high fre-
quency. A conflict be-
tween estimates of
allele age based on fre-
quency versus varia-
tion at linked genetic
markers can then be an
indication of selection
acting on the allele
(21). An example is the
DF508 mutation, which
is the most common
cause of cystic fibrosis in Europeans. This
mutation appears much younger than one
would expect, given its high frequency,
supporting the idea that DF508 heterozy-
gotes were favored by natural selection
because of an increased resistance to dis-
eases such as cholera. An intriguing pos-
sibility is that similar approaches could be
used to detect somatic mutations that
favor stem cell proliferation. Conflicts be-
Assuming one stem cell
division per day, this
would suggest a stem cell
bottleneck, for any given
crypt, about every 8.2
years, on average.
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tween the expected age of a mutant cell
lineage (a cell bearing a mutation in an
oncogene, for example), based on the
frequency of the mutant in a tissue, and
the age of the cell lineage as determined
by using epigenetic markers could be used
to identify cases of positive selection fa-
voring particular mutations (mutations
that increase the rate of stem cell prolif-
eration, for example). This could provide
a new tool for identifying precancerous
cells.
The epigenetic tagging approach devel-
oped by Yatabe et al. (3) appears very
promising. However, there are several
outstanding questions that need to be
addressed to establish the general utility
and reliability of their approach. First, the
accuracy (and reproducibility) of the ex-
perimental technique for inferring meth-
ylation patterns needs to be examined (22,
23). If the error rate (i.e., the chance of
incorrectly inferring that a nonmethylated
site is methylated) is high, this will in-
crease variation in the number of unique
tags per crypt and favor a stochastic
model, even if the deterministic model is
correct. Because the test of models is
based on the variance in the number of
distinct tags per crypt, many sources of
random error in assigning tags will bias
the test in favor of a stochastic model.
Second, more realistic models of stem cell
dynamics should be considered. Yatabe et
al. (3) treat the number of stem cells per
crypt, n, as constant in their model. If n
varies across crypts within individual pa-
tients, this would increase the variance in
the number of unique tags per crypt, again
favoring a stochastic model.
Other potential factors that could bias
test results, such as variation in methyl-
ation rates among crypts caused by endog-
enous, or exogenous, inf luences, have
been at least partially addressed. For ex-
ample, the percent methylation between
MYOD1 and CSX did not correlate within
single crypts as would be expected if some
common external influence were modify-
ing methylation rates at all CpG sites
within a crypt. Such correlations could
also arise because of shared genealogies
among genes within stem cells, however,
so this is not an unambiguous test of
variation in methylation rates among
crypts. Despite several outstanding tech-
nical questions, methods for studying stem
cell dynamics in humans using methyla-
tion-based epigenetic tags hold great
promise. If these approaches prove feasi-
ble in other tissues, and especially in can-
cer cells, the outcomes could be revolu-
tionary. Applying these methods to cancer
cells may be particularly problematic,
however, as rates of methylation may be
greatly enhanced in some cell lineages
(prohibiting the use of a common meth-
ylation rate of 1025 for all cells) and CpG
sites within, and among, genes may
become uncoupled because of somatic
recombination.
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